Cargando…
(18)F-FDG-PET in Mouse Models of Alzheimer's Disease
Suitable animal models and in vivo biomarkers are essential for development and evaluation of new therapeutic strategies in Alzheimer's disease (AD). (18)F-Fluorodeoxyglucose ((18)F-FDG)-positron-emission tomography (PET) is an imaging biomarker that allows the assessment of cerebral glucose me...
Autores principales: | Bouter, Caroline, Bouter, Yvonne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482246/ https://www.ncbi.nlm.nih.gov/pubmed/31058151 http://dx.doi.org/10.3389/fmed.2019.00071 |
Ejemplares similares
-
In vivo Imaging With (18)F-FDG- and (18)F-Florbetaben-PET/MRI Detects Pathological Changes in the Brain of the Commonly Used 5XFAD Mouse Model of Alzheimer's Disease
por: Franke, Timon N., et al.
Publicado: (2020) -
(18)F-FDG-PET Detects Drastic Changes in Brain Metabolism in the Tg4–42 Model of Alzheimer’s Disease
por: Bouter, Caroline, et al.
Publicado: (2019) -
Quantitative Brain Positron Emission Tomography in Female 5XFAD Alzheimer Mice: Pathological Features and Sex-Specific Alterations
por: Bouter, Caroline, et al.
Publicado: (2021) -
Analysis of Motor Function in the Tg4-42 Mouse Model of Alzheimer’s Disease
por: Wagner, Jannek M., et al.
Publicado: (2019) -
Effect of Point Spread Function Deconvolution in Reconstruction of Brain (18)F-FDG PET Images on the Diagnostic Thinking Efficacy in Alzheimer's Disease
por: Doyen, Matthieu, et al.
Publicado: (2021)